Success of covid antiviral pills hinges on access to speedy and accurate tests

By | November 22, 2021
Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic ā€” with a second option from Pfizer to follow shortly after.